We are live on ! Find out more
AGP

Artia Global Partners Portfolio holdings

AUM $542M
1-Year Est. Return 206.64%
This Fund
S&P 500
This Quarter Est. Return
+81.78%
1 Year Est. Return
+206.64%
3 Year Est. Return
+724.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$631M
AUM Growth
+$215M
Cap. Flow
+$61.2M
Cap. Flow %
9.7%
Top 10 Hldgs %
69.95%
Holding
56
New
19
Increased
12
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.2M
2
UGL icon
ProShares Ultra Gold
UGL
+$20.2M
3
ABVX
Abivax
ABVX
+$13.8M
4
SLNO
Soleno Therapeutics
SLNO
+$13.2M
5
QURE icon
uniQure
QURE
+$12M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$56.9M
2
SWTX
SpringWorks Therapeutics
SWTX
+$3M
3
INSM icon
Insmed
INSM
+$2.51M
4
LLY icon
Eli Lilly
LLY
+$1.49M
5
SRRK icon
Scholar Rock
SRRK
+$1.05M

Sector Composition

Rank Sector Weight
1 Healthcare 85.92%
2 Miscellaneous 13.84%
3 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALEC icon
51
Alector
ALEC
$276M
$210K 0.03%
+71,029
New +$156K
JANX icon
52
Janux Therapeutics
JANX
$1.23B
– –
-20,000
Closed -$462K
SWTX
53
DELISTED
SpringWorks Therapeutics
SWTX
– –
-63,930
Closed -$3M
UGL icon
54
CALL
ProShares Ultra Gold
UGL
$845M
– –
-168,000
Closed -$5.82M
VRNA
55
PUT
DELISTED
Verona Pharma
VRNA
– –
-91,800
Closed -$8.68M
XBI icon
56
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
– –
-100,000
Closed -$8.29M
1 2
3

Similar funds

CA
CV Advisors Aventura, Florida $542M AUM 24.89% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return
LI
Louisbourg Investments Dieppe, New Brunswick, Canada $542M AUM 21.44% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $541M AUM
FVCM
F&V Capital Management Boca Raton, Florida $542M AUM 46.38% 1-Year Est. Return
LI
Lafayette Investments Ashton, Maryland $542M AUM 22.5% 1-Year Est. Return
CCT
Chemung Canal Trust Elmira, New York $541M AUM 32.42% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

Artia Global Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Artia Global Partners held 56 positions worth $631M, up 52% from $416M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Artia Global Partners deployed $61.2M of net new capital in Q3 2025, opening 19 new positions and adding to 12 existing holdings. Its largest new stake was ProShares Ultra Gold: 537,372 shares worth $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 94% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Verona Pharma, an estimated $56.9M trimmed.

  • Artia Global Partners's largest Q3 2025 buy was ProShares Ultra Gold: 537,372 shares worth $24.8M.
  • Artia Global Partners added most to Vertex Pharmaceuticals in Q3 2025, an estimated $21.2M increase.
  • Artia Global Partners's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $56.9M.
  • Artia Global Partners fully exited SpringWorks Therapeutics in Q3 2025, selling an estimated $3M.
  • Artia Global Partners's ten largest holdings make up 70% of its $631M portfolio in Q3 2025.
  • Artia Global Partners opened 19 new positions and closed 5 in Q3 2025.
  • Artia Global Partners's portfolio value rose 52% quarter-over-quarter to $631M.

Based on Artia Global Partners's 13F filing for Q3 2025, filed 14 Nov 2025.